Rash erythematous: FDA reporting patterns
46,220 FDA FAERS reports mention Rash erythematous. 22,680 reports have a serious outcome flag.
Medicines named as suspect
- Dupilumab: 7,459 reports
- Adapalene: 2,506 reports
- Etanercept: 2,273 reports
- Octisalate: 2,207 reports
- Adalimumab: 2,203 reports
- Avobenzone: 2,203 reports
- Octocrylene: 1,971 reports
- Acetaminophen: 1,012 reports
- Amoxicillin: 982 reports
- Rituximab: 978 reports
- Infliximab: 969 reports
- Tocilizumab: 825 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.